Surviving the valley of death: A comparative analysis

Journal of Technology Transfer

Volumn 21, Issue 1-2, 1996, Pages 61-69

  Frank, Clyde ^a   Sink, Claire ^a   Mynatt, Leann ^a   Rogers, Richard ^a   Rappazzo, Andee ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 4344666746     PISSN: 08929912     EISSN: 15737047     Source Type: Journal    
DOI: 10.1007/BF02220308     Document Type: Article

References (20)

1. National Environmental Technology Applications Center. Barriers to Environmental Technology Commercialization. April 1995.
2. Kassebaum, Nancy Landon. "Revitalizing New Product Development from Clinical Trials Through PDA Review." Testimony: FDA Reform (February 21,1996).
3. Ward, Michael R., and David Dranova. The Vertical Chain of Research and Development in the Pharmaceutical Industry." Economic Inquiry (January 1995): 70-87.
4. U.S. Food & Drug Administration. "User Fees." FDA Backgrounder ( 1992)
5. VentureOne at Environmental Investing Conference, Nov. 10,1994.
6. Paterson, Andy. Phone conversation (August 14,1995).
7. Beltz, Cynthia, ed. Financing Entrepreneurs. Washington, DC: American Enterprise Institute Press, 1994.
8. U.S. Department of Health and Human Services. "Orientation Handbook for Members of Scientific Review Groups." HHS Publication, March 1992 Interim Revision.
9. Conlan, Michael F. "Congress Debates Price of Drug Found by Government Process." Drug Topics (February 22,1993): 44-45.
10. Conlan, Michael F. "Government R&D Contributions to Rx Firms Eyed Again." Drug Topics (April 5,1993): 59-60.
11. Schofield, John. Phone conversation (August 9,1995).
12. Preston, John T. "Key Problems in Commercializing Technology in the U.S." Presented as testimony before the Energy Subcommittee of the U.S. House of Representatives, Space Science and Technology Committee (March 23, 1993).
13. Preston, John T. "Success Factors in Technology Development." Industry & Higher Education 7, no. 4(1993): 207-215.
14. Preston, John T., and David H. Staelin. "National Strategies for Technology Commercialization." Technology Managements, no. 1 (1994): 30-34.
15. Preston, John T. Phone conversation (April 10,1996).
16. 21 Code of Federal Regulations 316.31.
17. Weck, Egon. "Medicine's Orphans: Drugs for Rare Diseases." From Test Tube to Patient New Drug Development in the United States. U.S. Food and Drug Administration (1990): 52-55.
18. Koberstein, Way ne, et al. The Future of Research: A Forecast for Pharmaceuticals." Pharmaceutical Executive (December 1994): 28-60.
19. Environmental Business International, Inc., Environmental Business Journal 8, no. 10 (October 1995): 2.
20. Bridge to a Sustainable Future. Washington, DC: National Science and Technology Council, April 1995.